Tom Loewald, Cambrex CEO

Af­ter Chi­nese CD­MO fails, Cam­brex ac­quires in­gre­di­ent man­u­fac­tur­er Snap­drag­on Chem­istry

While CD­MO Cam­brex has been ex­pand­ing steadi­ly through­out the year, its lat­est ac­qui­si­tion sees a deep­er dive in­to the ac­tive phar­ma­ceu­ti­cal in­gre­di­ent game.

The New …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.